Mahmut Yesin

Mahmut Yesin

Auto-generated profile, based on publicly available information

Mahmut Yesin

Kafkas University Faculty of Medicine, Department of Cardiology, Kars, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
YKYavuz Karabağ
Yavuz Karabağ
MÇMetin Çağdaş
Metin Çağdaş
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
SKSüleyman Karakoyun
Süleyman Karakoyun
IAİnAnç Artaç
İnAnç Artaç
ITIbrahim Halil Tanboğa
Ibrahim Halil Tanboğa

1 January 2018 in Korean Circulation Journal
Verified
Journal Article
Open access
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
MÇMetin Çağdaş
Metin Çağdaş
SKSüleyman Karakoyun
Süleyman Karakoyun
YKYavuz Karabağ
Yavuz Karabağ
MYMahmut Yesin
Mahmut Yesin
ITIbrahim Halil Tanboğa
Ibrahim Halil Tanboğa
Rencuzogullari I, et al. Korean Circ J. 2016 Sep;48:e8. https://doi.org/10.4070/kcj.2017.0058

15 April 2021 in Biomarkers in Medicine
Verified
Journal Article
Closed access
TOTimor Omar
Timor Omar
MKMuammer Karakayalı
Muammer Karakayalı
MYMahmut Yesin
Mahmut Yesin
HAHalil Can Alaydın
Halil Can Alaydın
YKYavuz Karabağ
Yavuz Karabağ
AGAyça Gümüşdağ
Ayça Gümüşdağ
Aim: Monocyte to high-density lipoprotein cholesterol ratio (MHR) has recently emerged as a predictor of cardio-cerebrovascular diseases. Since around one-fifth of strokes are linked to atheroscler...

1 January 2018 in Journal of Electrocardiology
Verified
Journal Article
Closed access
MYMahmut Yesin
Mahmut Yesin
MKMacit Kalçık
Macit Kalçık
MÇMetin Çağdaş
Metin Çağdaş
YKYavuz Karabağ
Yavuz Karabağ
IRİbRahim Rencüzoğulları
İbRahim Rencüzoğulları
SKSüleyman Karakoyun
Süleyman Karakoyun

29 June 2017 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
MYMahmut Yesin
Mahmut Yesin
MÇMetin Çağdaş
Metin Çağdaş
MKMacit Kalçık
Macit Kalçık
MUMahmut Uluganyan
Mahmut Uluganyan
SESüleyman Çağan Efe
Süleyman Çağan Efe
SKSüleyman Karakoyun
Süleyman Karakoyun

21 May 2020 in Vascular
Verified
Journal Article
Closed access
PDF file
MSMuhammed Süleymanoğlu
Muhammed Süleymanoğlu
CBCengiz Burak
Cengiz Burak
AGAyça Gümüşdağ
Ayça Gümüşdağ
MYMahmut Yesin
Mahmut Yesin
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
MÇMurat Çap
Murat Çap
Peripheral arterial disease is associated with increased cardiovascular mortality and morbidity. C-reactive protein and albumin are biomarkers of inflammation and malnutrition that play key roles in the pathophysiological pathways involved in the progression of atherosclerosis and peripheral arterial disease. In this study, we aimed to assess the relationship between C-reactive protein to albumin ratio and the suprapopliteal peripheral arterial disease severity and complexity as assessed by TransAtlantic Inter-Society Consensus-II (TASC-II) classification. Our study enrolled 224 consecutive patients referred for peripheral angiography with the clinical features of possible peripheral arterial disease at a tertiary care center between January 2016 and September 2019. Level of disease and lesion characteristics were defined with reference to angiographic findings according to the TASC-II classification. C-reactive protein/albumin ratio levels were significantly higher in TASC-II class C and D than in TASC-II class B patients with a median level of 1.8 to 2.1 vs 1.4, respectively (p = 0.018). In multivariate regression analysis, C-reactive protein to albumin ratio remained an independent predictor of severe peripheral arterial disease. The predictive performance of C-reactive protein to albumin ratio, C-reactive protein, and albumin were compared by Receiver Operating Characteristic curve analysis. C-reactive protein to albumin ratio surpassed C-reactive protein and albumin in predicting peripheral arterial disease severity and complexity. A level of C-reactive protein to albumin ratio > 0.14 predicted a higher grade of suprapopliteal TASC-II class with sensitivity and specificity of 68.2% and 56.0%, respectively. C-reactive protein to albumin ratio was strongly associated with peripheral arterial disease severity and complexity, as assessed by TASC-II classification. Also, C-reactive protein to albumin ratio was found to be a more accurate marker than C-reactive protein and albumin alone in predicting more severe and complex lesions in patients with peripheral arterial disease.